These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 7992097)
1. Use of interferon in the treatment of chronic myelogenous leukemia. Talpaz M Semin Oncol; 1994 Dec; 21(6 Suppl 14):3-7. PubMed ID: 7992097 [TBL] [Abstract][Full Text] [Related]
2. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group. Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674 [TBL] [Abstract][Full Text] [Related]
3. Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group. J Natl Cancer Inst; 1997 Nov; 89(21):1616-20. PubMed ID: 9362160 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia. Kantarjian HM; Talpaz M Semin Oncol; 1994 Dec; 21(6 Suppl 14):8-13. PubMed ID: 7992099 [TBL] [Abstract][Full Text] [Related]
6. Interferon alpha in the treatment of chronic myelogenous leukemia. Robak T Arch Immunol Ther Exp (Warsz); 1998; 46(6):347-53. PubMed ID: 9883313 [TBL] [Abstract][Full Text] [Related]
7. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia. Zuffa E; Bandini G; Bonini A; Santucci MA; Martinelli G; Rosti G; Testoni N; Zaccaria A; Tura S Haematologica; 1998 Mar; 83(3):231-6. PubMed ID: 9573677 [TBL] [Abstract][Full Text] [Related]
8. A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses. Peñarrubia MJ; Odriozola J; González C; Massagué I; Miguel A; González San Miguel JD; Pérez Encinas M; Lavilla E; Giraldo MP; Casado LF; Ferrer S; Steegmann JL; Ann Hematol; 2003 Dec; 82(12):750-8. PubMed ID: 14517691 [TBL] [Abstract][Full Text] [Related]
15. [Use of interferon in the treatment of chronic myeloproliferative disorders]. Robak T Acta Haematol Pol; 1992; 23(2 Suppl 1):30-7. PubMed ID: 1488870 [TBL] [Abstract][Full Text] [Related]
16. [Interferon alpha--the drug of choice for patients with chronic myeloid leukemia]. Klamová H; Vítek A; Michalová K; Brezinová J; Moravcová J; Jelínek J; Cermák J Cas Lek Cesk; 1998 Sep; 137(18):552-6. PubMed ID: 9818464 [TBL] [Abstract][Full Text] [Related]
17. Serum beta-2 microglobulin levels are a significant prognostic factor in Philadelphia chromosome-positive chronic myelogenous leukemia. Rodriguez J; Cortes J; Talpaz M; O'Brien S; Smith TL; Rios MB; Kantarjian H Clin Cancer Res; 2000 Jan; 6(1):147-52. PubMed ID: 10656443 [TBL] [Abstract][Full Text] [Related]
18. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells. Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574 [TBL] [Abstract][Full Text] [Related]
19. [Recent progress in therapy for chronic myelogenous leukemia]. Urabe A Gan To Kagaku Ryoho; 1997 Jul; 24(9):1066-73. PubMed ID: 9239158 [TBL] [Abstract][Full Text] [Related]
20. New perspectives with interferon alpha. The German CML study group experience. Hehlmann R; Ansari H; Adelberger V; Heinze B; Hossfeld K; Hochhaus A; Heimpel H Bone Marrow Transplant; 1994; 14 Suppl 3():S14-20. PubMed ID: 7697004 [No Abstract] [Full Text] [Related] [Next] [New Search]